ZhangWMcLeodCKoehoornM. The relationship between chronic conditions and absenteeism and associated costs in Canada. Scand J Work Environ Health. 2016;42(5):413–422.
2.
LambertJCaridesGWMelocheJPGerthWCMarentetteMA. Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial. Can J Clin Pharmacol. 2002;9(3):158–164.
3.
GfrererLHulsenJHMcLeodMDWrightEJAustenWGJr. Migraine surgery: an all or nothing phenomenon? prospective evaluation of surgical outcomes. Ann Surg. 2019;269(5):994–999.
4.
FaberCGarciaRMDavisJGuyuronB. A socioeconomic analysis of surgical treatment of migraine headaches. Plast Reconstr Surg. 2012;129(4):871–877.
5.
SchoenbrunnerARKhansaIJanisJE. Cost-effectiveness of long-term, targeted onabotulinumtoxina versus peripheral trigger site deactivation surgery for the treatment of refractory migraine headaches. Plast Reconstr Surg. 2020;145(2):401e–406e.
6.
HatefDAGutowskiKACulbertsonGRZielinskiMManahanMA. A comprehensive review of surgical treatment of migraine surgery safety and efficacy. Plast Reconstr Surg. 2020;146(2):187e–195e. doi:10.1097/prs.0000000000007020
7.
EisenbergMJFilionKBAzoulayABroxACHaiderSPiloteL. Outcomes and cost of coronary artery bypass graft surgery in the United States and Canada. Arch Intern Med. 2005;165(13):1506–1513.
8.
HealthOM. Physician Services Under the Health Insurance Act. 2021. Ontario.
